Lv4
500 积分 2022-02-11 加入
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
7天前
已完结
Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy
8天前
已完结
P3.13D.09 Prevalence and Prognostic Impact of SEZ6 Expression in a Real-World Cohort of Patients with Small-Cell Lung Cancer
12天前
已完结
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
16天前
已完结
Priming treatment with T-cell redirecting bispecific antibody ERY974 reduced cytokine induction without losing cytotoxic activity in vitro by changing the chromatin state in T cells
16天前
已完结
Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974
16天前
已完结
Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer
17天前
已完结
Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept study
30天前
已完结
Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma
1个月前
已完结
Matriptase (ST14, Suppressor of Tumorigenicity 14 Protein)
1个月前
已完结
皖公网安备34019202002308
